Decreased relapsed rate and treatment-related mortality contribute to improved outcomes for pediatric acute myeloid leukemia in successive clinical trials.
about
Decreased relapsed rate and treatment-related mortality contribute to improved outcomes for pediatric acute myeloid leukemia in successive clinical trials.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Decreased relapsed rate and tr ...... in successive clinical trials.
@en
type
label
Decreased relapsed rate and tr ...... in successive clinical trials.
@en
prefLabel
Decreased relapsed rate and tr ...... in successive clinical trials.
@en
P2093
P2860
P50
P356
P1433
P1476
Decreased relapsed rate and tr ...... in successive clinical trials
@en
P2093
Ching-Hon Pui
Hiroto Inaba
Raul C Ribeiro
P2860
P304
P356
10.1002/CNCR.30791
P407
P577
2017-05-30T00:00:00Z